The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

In Brief

OHSU and Cancer Research UK to collaborate on early detection

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

THE KNIGHT CANCER INSTITUTE at Oregon Health & Science University and Cancer Research UK formed an international collaboration focused on the early detection of cancer.

The collaboration seeks to address research models for the earliest stages of the disease; shortages of tissue samples available for research, especially samples from higher risk patients; and the need for a better understanding of the biology of early cancer and appropriate technologies to detect its features.

The collaboration will host an annual international conference series; in 2016, the conference will be titled “Cancer Research UK and OHSU Knight Cancer Institute present the Sondland-Durant Early Detection of Cancer Conference” in recognition of generous support from the Gordon D. Sondland and Katherine J. Durant Foundation.

Table of Contents

YOU MAY BE INTERESTED IN

PodcastThe Directors

The Directors: Wistar’s Altieri and ChristianaCare’s Petrelli say partnership of their institutions will go on as the guard changes

Leadership is changing at The Wistar Institute and the Helen F. Graham Cancer Center & Research Institute in the months to come—but the leaders of the two institutions say that this will have little if any effect on the clinical-research collaboration that they have spent the past 15years building (The Cancer Letter, July 12, 2019). 
By Sara Willa Ernst and Paul Goldberg
Trials & Tribulations

In the era of immunotherapy, response rate alone fails to predict true patient benefit
Regulators must adapt

March is National Colorectal Cancer Awareness Month. It is a reminder of a heartbreaking trend that oncologists like me are witnessing in our clinics: Last year, for the first time, colorectal cancer became the leading cause of cancer-related death in Americans under the age of 50, according to data published earlier this year in JAMA.
By Richard M. Goldberg
Table of Contents

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account